Subscribe to Newsletter

Screening and monitoring

Diagnostics Biochemistry and molecular biology

A Broader Approach to Virus Surveillance

| Helen Bristow

Inside the Lab Technology and innovation

Increasing Infection Detection

| Jessica Allerton

UK pilot tests advanced DNA sequencing to improve pathogen surveillance in hospitals
Inside the Lab Technology and innovation

Dropletronics

| Helen Bristow

Biocompatible electronic devices open up new possibilities for in situ disease detection
Inside the Lab Digital and computational pathology

Diagnostic Demands: Part 1

| Jessica Allerton | 4 min read

We asked our 2024 Power Listers what’s missing from the diagnostic toolbox – and what they’re eagerly anticipating in the years to come
Outside the Lab Screening and monitoring

Breeding Grounds

| Helen Bristow

COVID-19 incidence tied to school eligibility among young children
Outside the Lab Screening and monitoring

All-New Flu Patterns

| Helen Bristow

Pandemic restrictions significantly altered global spread of seasonal influenza, study finds
Outside the Lab Guidelines and recommendations

Identifying and Managing Prominent Priority Pathogens

| Jessica Allerton | 3 min read

Epidemiology survey results identify priorities and changes required in preparation for new disease outbreaks
Diagnostics Genetics and epigenetics

How COVID-19 Cardiovascular Risks Relate to Blood Type

| Helen Bristow

The chance of heart attacks and strokes is higher among COVID-19 patients with A, B, or AB blood types
Subspecialties Neurology

Timing Matters in Alzheimer’s Disease Diagnosis

| Helen Bristow

Dementia biomarkers levels are shown to vary according to the time of day
Outside the Lab Screening and monitoring

Gestational Diabetes Mellitus Screening Failures

| Helen Bristow

Diagnoses could be missed when pregnant patients are screened with the casual blood glucose test

Latest Application Notes

The Development of Plasma Amyloid-β Assay and its Significance in Alzheimer’s Disease

| Contributed by Shimadzu

The Future of Noninvasive Multi-Cancer Screening

| Contributed by Horizon Discovery

NEXTFLEX Variant-Seq™ SARS-CoV-2 Kit

| Contributed by Revvity

Diagnostics Screening and monitoring

Five Reasons to implement LC-MS platforms for your laboratory developed tests

| Contributed by Thermo Fisher Scientific

All Application Notes

Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register

December Issue of The Pathologist